Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $308.22M.
ENTERPRISE VALUE (EV)
$308.22M
Neurogene Inc.
Market Cap
$402.17M
Enterprise Value (EV)
$308.22M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Neurogene Inc. (NGNE) | $402.17M | $308.22M |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | $499.54M |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.74M | $329.61M |
| Carlsmed, Inc. (CARL)vs › | $397.99M | $373.66M |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | $515.79M |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | $387.32M |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | $398.94M |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | $341.56M |
| Rezolute, Inc. (RZLT)vs › | $415.98M | $406.30M |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | $433.36M |
Market Cap
$402.17M
Total Debt
$9.89M
Cash
$103.84M
Enterprise Value
$308.22M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
